Parenting Style and Peer Group Membership Among European-American Adolescents
In: Journal of research on adolescence, Volume 3, Issue 1, p. 87-100
ISSN: 1532-7795
70 results
Sort by:
In: Journal of research on adolescence, Volume 3, Issue 1, p. 87-100
ISSN: 1532-7795
Background: The current Ebola Virus Disease (EVD) outbreak in West Africa is the largest in history. As of February 18th 2015, 23,258 cases of EVD have been cumulatively reported from Nigeria, Senegal, Guinea, Liberia, Mali, Sierra Leone, Spain, the United Kingdom and the United States of America resulting in more than 9,000 deaths. It is therefore exigent to develop prevention and treatment therapies for EVD. Discussion: Several new EVD treatments are in clinical development at this time. Based on lessons learned, four critical processes need to be implemented before clinical trials begin. First, all global EVD research need to be coordinated to promote data sharing and synergistic overlap, while reducing unnecessary duplication of efforts. The World Health Organization is well-placed to undertake such an endeavor. Second, governments of affected nations where trials are being proposed need to lead discussions regarding immediate access to any proven medications for epidemics. Also, governments need to leverage international resources to support and expand existing national expertise to jointly conduct high-caliber clinical research; and resources must be used to enhance local technical skills and expand existing personnel. Third, ethics committees must review protocols, monitor the research process, and work closely with research scientists to insure the ethical integrity of research throughout the trials. Fourth, community advisory boards (CAB) need to be formed, linked with existing community leadership structures and organized in conjunction with trial implementation. These community structures should work together with ethics committees to facilitate the study design, informed consent process, and study implementation. Summary: We must facilitate communication and mutual understanding between trial communities and research teams, and promote positive collaborations between all stakeholders engaged in EVD research. The community engagement process for EVD research is crucial to address myths and misconceptions, and to promote study volunteers' understanding of the research details. The collaboration between all stakeholders is crucial for continued long term partnership to address EVD outbreak and none of the stakeholders should be left behind in ongoing efforts to develop EVD therapies.
BASE
In: Risk analysis: an international journal, Volume 13, Issue 6, p. 637-642
ISSN: 1539-6924
Lifetime cancer potency of alfatoxin was assessed based on the Yeh et al. study from China in which both aflatoxin exposure and hepatitis B prevalence were measured. This study provides the best available information for estimating the carcinogenic risk posed by aflatoxin to the U.S. population. Cancer potency of aflatoxin was estimated using a biologically motivated risk assessment model. The best estimate of aflatoxin potency was 9 (mg/kg/day)−1 for individuals negative for hepatitis B and 230 (mg/kg/day)−1 for individuals positive for hepatitis B.
In: Journal of research on adolescence, Volume 12, Issue 1, p. 31-68
ISSN: 1532-7795
Trends across nations suggest that adulthood in the future will require greater social versatility, including abilities to function in relationships that are less scripted by community norms and that bridge multiple social worlds. This article assesses whether current changes in adolescents' interpersonal experience are likely to give them the social resources and competencies they will need. Changes in families are making them smaller, more diverse in social capital, and more responsive to adolescents. Changes in adolescents' nonfamily experience include more time in institutional settings; more involvement with peers; and more cycles of developing (and ending) relationships with a heterogeneous set of adults, friends, and, for many, romantic partners. The analysis suggests that these changes will provide many youth with greater opportunities to develop the more versatile interpersonal resources required in the future, but that many adolescents will have restricted opportunities to acquire these resources.
In: New directions for youth development: theory, research, and practice, Volume 2005, Issue 105, p. 121-129
ISSN: 1537-5781
AbstractExperience sampling methodology was used to measure engagement during the after‐school hours. Experiences that combined high levels of intrinsic motivation with concerted effort and enjoyment were more likely at after‐school programs than elsewhere.
The β decay of 207Hg into the single-proton-hole nucleus 207Tl has been studied through γ -ray spectroscopy at the ISOLDE Decay Station (IDS) with the aim of identifying states resulting from coupling of the πs −1 1/2, πd−1 3/2, and πh−1 11/2 shell model orbitals to the collective octupole vibration. Twenty-two states were observed lying between 2.6 and 4.0 MeV, eleven of which were observed for the first time, and 78 new transitions were placed. Two octupole states (s1/2-coupled) are identified and three more states (d3/2-coupled) are tentatively assigned using spin-parity inferences, while further h11/2-coupled states may also have been observed for the first time. Comparisons are made with state-of-the-art large-scale shell model calculations and previous observations made in this region, and systematic underestimation of the energy of the octupole vibrational states is noted. We suggest that in order to resolve the difference in predicted energies for collective and noncollective t = 1 states (t is the number of nucleons breaking the 208Pb core), the effect of t = 2 mixing may be reduced for octupole-coupled states. The inclusion of mixing with t = 0, 2, 3 excitations is necessary to replicate all t = 1 state energies accurately. ; The research leading to these results has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 654002. Support from the European Union Seventh Framework through ENSAR Contract No. 262010, the Science and Technology Facilities Council (UK), the MINECO Projects No. FPA2015-64969-P and No. FPA2017-87568-P (Spain), FWO Vlaanderen (Belgium), GOA/2015/010 (BOF KU Leuven), the Excellence of Science Programme (EOS-FWO), the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (BriX network P7/12), the German BMBF under Contract No. 05P18PKCIA + "Verbundprojekt 05P2018," the Polish National Science Centre under Contracts No. UMO-2015/18/M/ST2/00523 and No. UMO-2019/33/N/ST2/03023, the National Science Foundation (US) Grant No. PHY-1811855 and the Romanian IFA project CERN-RO/ISOLDE is acknowledged. P.H.R. and S.M.J. acknowledge support from the UK Department for Business, Energy and Industrial Strategy via the National Measurement Office.
BASE
13 pags., 5 figs., 2 tabs. ; The structure of Po208 populated through the EC/β+ decay of At208 is investigated using γ-ray spectroscopy at the ISOLDE Decay Station. The presented level scheme contains 27 new excited states and 43 new transitions, as well as a further 50 previously observed γ rays which have been (re)assigned a position. The level scheme is compared to shell model calculations. Through this analysis approximately half of the β-decay strength of At208 is found to proceed via allowed decay and half via first-forbidden decay. The first-forbidden transitions predominantly populate core excited states at high excitation energies, which is qualitatively understood using shell model considerations. This mass region provides an excellent testing ground for the competition between allowed and first-forbidden β-decay calculations, important for the detailed understanding of the nucleosynthesis of heavy elements. ; The research leading to these results received funding from the European Union's Horizon 2020 research and innovation program under Grant Agreement No. 654002. Support from the European Union Seventh Framework through ENSAR Contract No. 262010, as well as the Science and Technology Facilities Council (U.K.) through Grants No. ST/P005314/1, No. ST/L005743/1, No. ST/J000051/1, No. ST/L005670/1, and No. ST/P004598/1, the German BMBF under Contract No. 05P18PKCIA and "Verbundprojekt 05P2018" as well as Spanish MINECO Grants No. FPA2015-65035- P and No. FPA2017-87568-P, FWO Vlaanderen (Belgium), GOA/2015/010 (BOF KU Leuven), the Excellence of Science Programme (EOS-FWO), the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (BriX network P7/12), the Polish National Science Centre under Contracts No. UMO-2015/18/M/ST2/00523 and No. UMO-2019/33/N/ST2/03023, National Science Foundation (U.S.) Grant No. PHY1811855, and the Romanian IFA project CERN-RO/ISOLDE is acknowledged. P.H.R. acknowledges support from the U.K. Department for Business, Energy and Industrial Strategy via the National Measurement Office ; Peer reviewed
BASE
Background Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16–30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77–0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50–0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80–0·88; p<0·001), and full lockdowns (0·57, 0·54–0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11 827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long-term investment in surge capacity for acute care during public health emergencies to protect elective staff and services. Funding National Institute for Health Research Global Health Research Unit, Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.
BASE
Background Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16–30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77–0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50–0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80–0·88; p<0·001), and full lockdowns (0·57, 0·54–0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long- term investment in surge capacity for acute care during public health emergencies to protect elective staff and services. Funding National Institute for Health Research Global Health Research Unit, Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.
BASE